The Research and Development team at Silence Therapeutics Plc focuses on advancing RNA interference technologies to develop innovative gene therapies. This multidisciplinary group, comprising scientists and medical experts, works collaboratively to design, test, and refine drug candidates for various disease applications, ensuring rigorous scientific standards and effective drug discovery processes. Their efforts aim to translate cutting-edge research into viable therapeutic solutions.
Annemieke Aartsma-Ru...
Scientific Advisor
Gordon Duff
Chairman, Scientific Advisory ...
Henry Ginsberg
Scientific Advisor
Jenny Sims
Scientific Advisor
John Porter
Scientific Advisor
John Whittaker
Scientific Advisor
Melanie B.
Senior Research Associate In T...
Steffen Schubert
Vice President Drug Discovery
Steven Romano
Chief Medical Officer and Head...
Tom Brown
Scientific Advisor
View all